COVID-19 Vaccine Perception in South Korea: Web Crawling Approach

Author:

Lee HocheolORCID,Noh Eun BiORCID,Park Sung JongORCID,Nam Hae KweunORCID,Lee Tae HoORCID,Lee Ga RamORCID,Nam Eun WooORCID

Abstract

Background The US Centers for Disease Control and Prevention and the World Health Organization emphasized vaccination against COVID-19 because physical distancing proved inadequate to mitigate death, illness, and massive economic loss. Objective This study aimed to investigate Korean citizens’ perceptions of vaccines by examining their views on COVID-19 vaccines, their positive and negative perceptions of each vaccine, and ways to enhance policies to increase vaccine acceptance. Methods This cross-sectional study analyzed posts on NAVER and Instagram to examine Korean citizens’ perception of COVID-19 vaccines. The keywords searched were “vaccine,” “AstraZeneca,” and “Pfizer.” In total 8100 posts in NAVER and 5291 posts in Instagram were sampled through web crawling. Morphology analysis was performed, overlapping or meaningless words were removed, sentiment analysis was implemented, and 3 public health professionals reviewed the results. Results The findings revealed a negative perception of COVID-19 vaccines; of the words crawled, the proportion of negative words for AstraZeneca was 71.0% (476/670) and for Pfizer was 56.3% (498/885). Among words crawled with “vaccine,” “good” ranked first, with a frequency of 13.43% (312/2323). Meanwhile, “side effect” ranked highest, with a frequency of 29.2% (163/559) for “AstraZeneca,” but 0.6% (4/673) for “Pfizer.” With “vaccine,” positive words were more frequently used, whereas with “AstraZeneca” and “Pfizer” negative words were prevalent. Conclusions There is a negative perception of AstraZeneca and Pfizer vaccines in Korea, with 1 in 4 people refusing vaccination. To address this, accurate information needs to be shared about vaccines including AstraZeneca, and the experiences of those vaccinated. Furthermore, government communication about risk management is required to increase the AstraZeneca vaccination rate for herd immunity before the vaccine expires.

Publisher

JMIR Publications Inc.

Subject

Public Health, Environmental and Occupational Health,Health Informatics

Reference36 articles.

1. Countries where COVID-19 has spreadWorldometer20202021-08-16https://www.worldometers.info/coronavirus/countries-where-coronavirus-has-spread/

2. International Monetary FundThe Great Lockdown: Worst Economic Downturn Since the Great Depression20202021-08-16https://blogs.imf.org/2020/04/14/the-great-lockdown-worst-economic-downturn-since-the-great-depression/

3. HoganAWinskillPWatsonOWalkerPGTWhittakerCBaguelinMHawDLøchenAGaythorpeKAMImperial College COVID-19 Response TeamMuhibFSmithPHauckKFergusonNMGhaniACReport 33: Modelling the Allocation and Impact of a COVID-19 Vaccine Imperial College London20202021-08-16https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/report-33-vaccine/

4. Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years

5. Coronavirus (COVID-19) Vaccinations2021-08-16https://ourworldindata.org/covid-vaccinations

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3